Inventor · disambiguated record
Ravi K. Pandrapragada
Also filed as: PANDRAPRAGADA RAVI K · PANDRAPRAGADA RAVI KUMAR
9 granted patents·3 pending applications·37 citations·filing 2015–2025
86Inventor score
Top patents by PatentIndex Score
12 records- 0197US10829465B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Nov 10, 2020·10 cites·20 claims
- 0295US10611744B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·10 cites·9 claims
- 0394US10071977B2Highly purifid pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·14 cites·24 claims
- 0493US11760740B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Sep 19, 2023·1 cites·40 claims
- 0591US11566011B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·1 cites·5 claims
- 0686US12049457B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2023·Granted Jul 30, 2024·0 cites·28 claims
- 0786US11203581B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2020·Granted Dec 21, 2021·1 cites·12 claims
- 0880US12290506B2Compositions and formulations for use of a PK inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2024·Granted May 6, 2025·0 cites·21 claims
- 0976US2025320188A1Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1074US2025367097A1Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2023·Application pending·0 cites
- 1170US12304896B2Highly purified pharmaceutical grade tasimelteonVANDA PHARMACEUTICALS INC·Filed 2024·Granted May 20, 2025·0 cites·17 claims
- 1264US2025228822A1Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disordersDERMBIONT INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →